Literature DB >> 26983447

Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells.

Yukio Nishimura1, Sumiko Hyuga2, Soichi Takiguchi3, Masashi Hyuga4, Kazuyuki Itoh5, Toshihiko Hanawa2.   

Abstract

The MET tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), are known to be overexpressed in a variety of malignant tumor cells, and are implicated in the development of gefitinib-resistance in human non-small cell lung cancer (NSCLC) cells. Ephedrae herba was previously reported to prevent HGF-induced cancer cell motility by directly suppressing HGF/MET signaling through the inhibition of MET tyrosine kinase, and treatment with its extract also considerably reduced MET protein levels. To further investigate the mechanism underlying the Ephedrae herba-induced inhibition of MET phosphorylation as well as its degradation and subsequent disappearance, we examined the effect of Ephedrae herba on HGF-stimulated MET endocytosis and downregulation via early/late endocytic pathways in an NSCLC cell line. Using immunofluorescence microscopy, we found that pretreatment of cells with Ephedrae herba extract dramatically changed the intracellular distribution of plasma membrane-associated MET, and that the resultant MET staining was distributed throughout the cytoplasm. Pretreatment of the cells with Ephedrae herba extract also led to the rapid loss of MET and phosphorylated (p)-MET in HGF-stimulated cells. In contrast, inefficient endocytic delivery of MET and p-MET from early to late endosomes was observed in the absence of Ephedrae herba extract, since considerable amounts of the internalized MET accumulated in the early endosomes and were not delivered to lysosomes up to 1 h after HGF-stimulation. Furthermore, large amounts of MET and p-MET that had accumulated in late endosomes of Ephedrae herba-pretreated cells after HGF stimulation were observed along with bafilomycin A1. Therefore, we inferred that degradation of MET occurred in the late endosome/lysosome pathway. Moreover, western blot analysis revealed the accelerated degradation of MET and p-MET proceeds in cells pretreated with Ephedrae herba extract. Collectively, our results suggest that some components of Ephedrae herba have a novel role in promoting HGF-stimulated MET and p-MET endocytosis followed by its downregulation, likely mediated by the early/late endocytic pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26983447     DOI: 10.3892/ijo.2016.3426

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Two flavone C-glycosides as quality control markers for the manufacturing process of ephedrine alkaloids-free Ephedra Herb extract (EFE) as a crude drug preparation.

Authors:  Naohiro Oshima; Takuro Maruyama; Tadatoshi Yamashita; Nahoko Uchiyama; Yoshiaki Amakura; Sumiko Hyuga; Masashi Hyuga; Shunsuke Nakamori; Hiroaki Takemoto; Yoshinori Kobayashi; Takashi Hakamatsuka; Hiroshi Odaguchi; Toshihiko Hanawa; Yukihiro Goda
Journal:  J Nat Med       Date:  2017-08-03       Impact factor: 2.343

2.  Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma.

Authors:  Qianqian Wang; Xiangyuan Yu; Qiang Li; Linyuan Qin; Shengkui Tan; Xiaoyun Zeng; Xiaoqiang Qiu; Bo Tang; Junfei Jin; Weijia Liao; Moqin Qiu; Lijun Tan; Gaofeng He; Xiaomei Li; Songqing He; Hongping Yu
Journal:  Oncotarget       Date:  2016-11-29

3.  Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells.

Authors:  Chhanda Bose; Ashly Hindle; Jihyun Lee; Jonathan Kopel; Sahil Tonk; Philip T Palade; Sharad S Singhal; Sanjay Awasthi; Sharda P Singh
Journal:  Cancers (Basel)       Date:  2021-12-20       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.